GRTS - Why Is Gritstone Bio Stock Trading Lower? | Benzinga
Gritstone bio Inc (NASDAQ:GRTS) shares are trading lower after the company announced an approximately 40% reduction of its workforce.
The move comes following the recently announced delay of the proposed CORAL Phase 2b study, which resulted in Gritstone not receiving the external funding it previously anticipated, beginning in the first quarter of 2024, associated with the initiation of the study.
In September, Gritstone Bio was awarded a contract by the Biomedical Advanced Research and Development Authority ...